| Literature DB >> 21598016 |
Abstract
Rheumatologists increasingly face patient questions about the need, the safety and the effectiveness of travel-related vaccinations. Currently, there are no guidelines on travel vaccinations for patients with inflammatory rheumatic diseases. The use of live attenuated vaccines remains contraindicated in patients receiving relevant immunosuppressive therapy despite some encouraging results from initial pilot studies. However, many inactivated travel vaccines can safely be used for patients with rheumatic diseases. Furthermore, rheumatologists should be vigilant in identifying and closing gaps in the routine vaccinations for patients.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21598016 DOI: 10.1007/s00393-010-0721-2
Source DB: PubMed Journal: Z Rheumatol ISSN: 0340-1855 Impact factor: 1.372